Related by context. Frequent words. (Click for all words.) 69 Pivotal Phase III 66 Pivotal Phase 65 Meets Primary Endpoint 65 refractory chronic lymphocytic 64 ongoing Phase 1b 64 Preclinical Data 64 Initiate Phase 64 Initiates Phase II 63 Phase Ib clinical 62 Phase Ib II 62 Clinical Trial Results 62 Randomised 62 Golimumab 62 Drug Candidate 62 Acute Ischemic Stroke 62 Sapacitabine 62 Benign Prostatic Hyperplasia 62 recurrent glioblastoma multiforme 62 Pharmacokinetic 62 Receives Orphan Drug Designation 62 Randomized controlled 61 Phase III Clinical Trial 61 Pralatrexate 61 Renal Cell Carcinoma 61 CIMZIA TM 61 relapsing multiple sclerosis 61 teriflunomide 61 Chronic Hepatitis C 61 Daclizumab 61 Etanercept 61 Completes Enrollment 60 elotuzumab 60 Natalizumab 60 Improves Survival 60 THE GERMAN SECURITIES 60 Ambrisentan 60 Significantly Improved 60 phase Ib 60 Well Tolerated 60 Traficet EN 60 Natural Catastrophe Stress 60 APTIVUS 60 Epratuzumab 59 Monotherapy 59 PRIVATE SECURITIES LITIGATION REFORM 59 plus OBT 59 Pirfenidone 59 dose escalation clinical 59 GSK# [001] 59 Lubiprostone 59 Diabetic Neuropathy 59 Epidermal Growth Factor Receptor 59 II Clinical Trial 59 Adalimumab 59 INVESTORS BID UP 59 Dasatinib 59 nab paclitaxel 59 metastatic castration resistant 59 J Am Coll 59 phase IIb clinical 59 Phase IIB 59 Zoraxel 58 ARCOXIA 58 DDP# 58 AVADO 58 Lacosamide 58 Confirmatory 58 Coadministration 58 Meta Analysis 58 Study Demonstrates 58 preclinical efficacy 58 DLTs 58 SCH # 58 Pivotal Study 58 Endometrial Cancer 58 phase IIa clinical 58 Pivotal Trial 58 liposomal formulation 58 J Am Soc 58 J Am Acad 58 Percutaneous Coronary Intervention 58 tigecycline 58 Solid Tumors 58 pharmacokinetics PK 58 Bortezomib 58 proteasome inhibitor 58 Low Dose 57 Myelofibrosis 57 Idiopathic Pulmonary Fibrosis 57 Bioequivalence 57 pharmacodynamic effects 57 Avanafil 57 Phase III Trial 57 transaminases 57 Phase IIIb 57 lanthanum carbonate 57 Chronic Lymphocytic Leukemia 57 RADIANT 57 tocilizumab 57 #th Annual Interscience 57 Accelerated Approval